about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Ab­b­Vie asks Supreme Court to re­con­sid­er rul­ing on at­tor­ney-client com­mu­ni­ca­tion

12 months ago
Pharma
Law

Ab­b­Vie CSO Tom Hud­son to re­tire, re­placed by med­ical chief

12 months ago
People
R&D

Ar­cutis tacks on atopic der­mati­tis ap­proval for Zo­ryve cream

Last year
Pharma
FDA+

Six big R&D ques­tions for Pfiz­er as sci­ence chief Dol­sten ex­its

Last year
R&D

Ac­quired biotech ac­cus­es No­var­tis of let­ting IL-15 as­set 'with­er on the vine'

Last year
Pharma
Law

Lil­ly bests No­vo Nordisk in ob­ser­va­tion­al study of GLP-1 drugs

Last year
R&D
Pharma

Ex­perts want to make it eas­i­er to get RSV vac­cines. Did they make it hard­er in­stead?

Last year
Pharma

Mod­er­na wins $176M BAR­DA award to fi­nance bird flu work

Last year
R&D
Pharma

Cas­sa­va says two se­nior em­ploy­ees in­clud­ed in fed­er­al probes

Last year
Pharma
Law

Aerovate plans to lay off near­ly all em­ploy­ees af­ter tri­al fail­ure

Last year
People
R&D

EMA's CHMP rec­om­mends 10 new drugs as Pierre Fab­re over­ac­tive blad­der med wins ap­proval

Last year
R&D
Pharma

In­side BAR­DA's multi­bil­lion-dol­lar ef­fort to fund long-shot biotechs for Covid

Last year
Pharma
Coronavirus

Lykos takes an­oth­er hit as ICER lays out 'in­suf­fi­cien­t' ev­i­dence for MD­MA-based treat­ment

Last year
R&D
Pharma

Up­dat­ed: CDC ex­pands RSV vac­cine rec­om­men­da­tions, name­ly for adults 75 and old­er

Last year
Pharma
FDA+

Mod­er­na's up­dat­ed RSV vac­cine dis­ap­points with on­ly 50% ef­fi­ca­cy

Last year
R&D
Pharma

Lil­ly be­comes the lat­est phar­ma to tap Ope­nAI for help, this time for an­tibi­ot­ic work

Last year
R&D
AI

Ko­rea-based Bridge Bio­ther­a­peu­tics clos­es Boston of­fice

Last year
Pharma

UK taps Pfiz­er over home­town GSK to sup­ply RSV vac­cine dos­es

Last year
Pharma

Lykos’ pain is oth­ers’ gain as psy­che­del­ic biotechs take notes from ad­comm vote

Last year
R&D
In Focus

FDA to phar­ma com­pa­nies: Us­ing CRO Synapse's stud­ies 'u­nac­cept­able'

Last year
Outsourcing
Pharma

Cor­rect­ed: Emer­gent sells Bal­ti­more fa­cil­i­ty for $30M

Last year
Pharma
Manufacturing

In­tra-Cel­lu­lar re­ports a de­pres­sion win, set­ting up fu­ture com­pe­ti­tion with Ab­b­Vie's Vray­lar

Last year
R&D
Pharma

GSK read­ies Blenrep's com­mer­cial re-launch in the US, and a push in sec­ond line

Last year
R&D
Pharma

Aerovate’s stock craters af­ter PAH drug fails Phase 2 study

Last year
Financing
R&D
First page Previous page 1112131415 Next page Last page
A service from the Financial Times